Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations.
Trisha A JenkinsPublished in: Current diabetes reports (2022)
Models of vascular cognitive impairment and vascular dementia, whether they develop from an infarct or non-infarct base, demonstrate increased neuroinflammation, reduced neuronal function and deficits in prefrontal and hippocampal-associated cognitive domains. Promising new research shows agents and environmental interventions that inhibit central oxidative stress and inflammation can reverse both pathology and cognitive dysfunction. While preclinical studies suggest that reversal of deficits in vascular cognitive impairment models is possible, replication in patients still needs to be demonstrated.
Keyphrases
- cognitive impairment
- oxidative stress
- metabolic syndrome
- traumatic brain injury
- end stage renal disease
- acute myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- type diabetes
- prognostic factors
- physical activity
- stem cells
- dna damage
- cell therapy
- mild cognitive impairment
- heart failure
- left ventricular
- mesenchymal stem cells
- patient reported
- signaling pathway
- case control
- human health
- heat shock protein
- temporal lobe epilepsy